M
Michael Braun
Researcher at Ludwig Maximilian University of Munich
Publications - 96
Citations - 1597
Michael Braun is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 17, co-authored 76 publications receiving 1105 citations. Previous affiliations of Michael Braun include BMW.
Papers
More filters
Proceedings ArticleDOI
At Your Service: Designing Voice Assistant Personalities to Improve Automotive User Interfaces
TL;DR: The results show higher likability and trust for assistants that correctly match the user's personality while lower likability, trust, satisfaction, and usefulness for incorrectly matched personalities, each in comparison with the Default character.
Journal ArticleDOI
De-escalation strategies in HER2-positive early breast cancer (EBC): final analysis of the WSG-ADAPT HER2+/HR- phase II trial: efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel.
Ulrike Nitz,O Gluz,Matthias Christgen,E-M. Grischke,Doris Augustin,Sherko Kuemmel,Michael Braun,Jochem Potenberg,A. Kohls,Katja Krauss,Andrea Stefek,Claudia Schumacher,Helmut Forstbauer,T. Reimer,Hans-Peter Fischer,Cornelia Liedtke,Rachel Wuerstlein,Johannes Schumacher,Ronald E. Kates,Hans Heinrich Kreipe,Nadia Harbeck +20 more
TL;DR: Addition of taxane monotherapy to dual HER2 blockade in a 12-week neoadjuvant setting substantially increases pCR rates in HER2+/HR- EBC compared with dual blockade alone, even within early responders to dual blockade.
Journal ArticleDOI
Combined Transvaginal B-Mode and Color Doppler Sonography for Differential Diagnosis of Ovarian Tumors: Results of a Multivariate Logistic Regression Analysis
Marcus Schelling,Michael Braun,Walther Kuhn,Gerhard Bogner,Robert Gruber,Joachim Gnirs,Karl Theo Mario Schneider,Kurt Ulm,Stefan Rutke,Alf Staudach +9 more
TL;DR: The combination of sonography and Doppler sonography achieves high and reproducible diagnostic accuracy in preoperative malignancy status assessment of adnexal tumors.
Journal ArticleDOI
Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results.
Oleg Gluz,Ulrike Nitz,Cornelia Liedtke,Matthias Christgen,Eva-Maria Grischke,Helmut Forstbauer,Michael Braun,Mathias Warm,John Hackmann,Christoph Uleer,Bahriye Aktas,Claudia Schumacher,Nikola Bangemann,Christoph Lindner,Sherko Kuemmel,Michael J. Clemens,Jochem Potenberg,Peter Staib,A. Kohls,Raquel von Schumann,Ronald E. Kates,Johannes Schumacher,Rachel Wuerstlein,Hans Kreipe,Nadia Harbeck +24 more
TL;DR: This first large randomized trial suggests high efficacy and excellent tolerability of a neoadjuvant nab-paclitaxel/carboplatin regimen, superior to nab- paclitaxe/gemcitabine in TNBC, and recommends de-escalation of further chemotherapy after a short anthracycline-free regimen.
Journal ArticleDOI
Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients.
Kerstin Hermelink,Markus Bühner,Philipp Sckopke,Franziska Neufeld,Judith Kaste,Varinka Voigt,Karin Münzel,Rachel Wuerstlein,Nina Ditsch,Karin Hellerhoff,Dorothea Rjosk-Dendorfer,Michael Braun,Franz Koch,Kristin Härtl,Stephan Hasmüller,Ingo Bauerfeind,Gerlinde Debus,Peter Herschbach,Sven Mahner,Nadia Harbeck +19 more
TL;DR: Largely irrespective of chemotherapy, breast cancer patients may encounter very subtle cognitive dysfunction, part of which is mediated by cancer-related post-traumatic stress.